Control of Brain State Transitions with a Photoswitchable Muscarinic Agonist

dc.contributor.authorBarbero Castillo, Almudena
dc.contributor.authorRiefolo, Fabio
dc.contributor.authorMatera, Carlo
dc.contributor.authorCaldas Martínez, Sara
dc.contributor.authorMateos Aparicio, Pedro
dc.contributor.authorWeinert, Julia F.
dc.contributor.authorGarrido Charles, Aida
dc.contributor.authorClaro Izaguirre, Enrique
dc.contributor.authorSánchez-Vives, María Victoria
dc.contributor.authorGorostiza Langa, Pablo Ignacio
dc.date.accessioned2021-06-08T08:13:03Z
dc.date.available2021-06-08T08:13:03Z
dc.date.issued2021-05-21
dc.descriptionReproducció del document publicat a:https://doi.org/10.1002/advs.202005027ca
dc.description.abstractThe ability to control neural activity is essential for research not only in basic neuroscience, as spatiotemporal control of activity is a fundamental experimental tool, but also in clinical neurology for therapeutic brain interventions. Transcranial-magnetic, ultrasound, and alternating/direct current (AC/DC) stimulation are some available means of spatiotemporal controlled neuromodulation. There is also light-mediated control, such as optogenetics, which has revolutionized neuroscience research, yet its clinical translation is hampered by the need for gene manipulation. As a drug-based light-mediated control, the effect of a photoswitchable muscarinic agonist (Phthalimide-Azo-Iper (PAI)) on a brain network is evaluated in this study. First, the conditions to manipulate M2 muscarinic receptors with light in the experimental setup are determined. Next, physiological synchronous emergent cortical activity consisting of slow oscillations—as in slow wave sleep—is transformed into a higher frequency pattern in the cerebral cortex, both in vitro and in vivo, as a consequence of PAI activation with light. These results open the way to study cholinergic neuromodulation and to control spatiotemporal patterns of activity in different brain states, their transitions, and their links to cognition and behavior. The approach can be applied to different organisms and does not require genetic manipulation, which would make it translational to humans.ca
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid34018704
dc.identifier.urihttps://hdl.handle.net/2445/178112
dc.language.isoengca
dc.publisherWiley-VCHca
dc.relation.ispartofAdvanced Science, 2021
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/945539/EU//HBP SGA3
dc.relation.urihttps://doi.org/10.1002/advs.202005027
dc.rightscc by (c) Barbero Castillo et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
dc.subject.classificationNeurociències
dc.subject.classificationNeurologia
dc.subject.otherNeurosciences
dc.subject.otherNeurology
dc.titleControl of Brain State Transitions with a Photoswitchable Muscarinic Agonistca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
doi_10.1002_advs.202005027.pdf
Mida:
1.84 MB
Format:
Adobe Portable Document Format